Skip to content

The effect of adding omega-3 in bipolar patients during manic period requiring ECT.

The effectiveness of omega-3 adjuvant therapy to Electroconvulsive therapy (ECT) in bipolar patients in a manic episode

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160523028008N26
Enrollment
50
Registered
2022-09-13
Start date
2022-08-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, current episode manic severe with psychotic features. Bipolar Disorder, current episode manic severe with psychotic features

Interventions

Intervention 1: Intervention group: 25 patients with bipolar disorder in the mania phase are treated with electroshock therapy with 100 mg omega-3 capsules (manufactured by Zahravi company) as a singl

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Bipolar patients in the acute phase of mania who, according to the physician, needed ECT Age greater than or equal to 18 Young Mania Rating Scale greater than or equal to 20 Having at least fifth grade education

Exclusion criteria

Exclusion criteria: Psychiatric disorders except Bipolar Disorder Pregnancy or breastfeeding Having a history of substance abuse in the last 2 weeks or addiction in the last 2 months Having a systemic disease

Design outcomes

Primary

MeasureTime frame
Mania symptoms. Timepoint: Before the intervention, after the fourth and eighth sessions of ECT. Method of measurement: Young Mania Rating Scale (YMRS).;Cognitive function. Timepoint: Before and after the intervention. Method of measurement: Cognitive function Test by using Montreal Cognitive Assessment.;Sleep quality. Timepoint: Before and after the intervention. Method of measurement: Pittsburgh Sleep Quality Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhadijeh Arabloo

Hamedan University of Medical Sciences

Kharabloo1358@gmail.com+98 81 1828 5015

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026